KalVista Pharmaceuticals KALV Aperçu des données financières et fondamentales

Compte de résultat

Quarter End	Avr 2022	Juil 2022	Oct 2022	Jan 2023	Avr 2023	Juil 2023	Oct 2023	Jan 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actif total	203,88M	182,32M	162,84M	203,47M	183,2M	160,33M	138,74M	113,97M
Total de l'actif circulant	193,65M	170,41M	151,22M	192,13M	172,33M	149,84M	128,61M	104,1M
Trésorerie et équivalents	30,73M	37,86M	38,59M	85,05M	56,24M	49,41M	57,67M	23,06M
Total des actifs non courants	12,41M	11,91M	11,62M	11,34M	13,82M	2,92M	2,84M	9,87M
Total des passifs	18,79M	17,75M	19,03M	19,03M	22,18M	21M	24,3M	25,39M
Total des passifs courants	11,58M	9,73M	11,32M	11,61M	15,03M	14,13M	17,75M	19,13M
Total des passifs non courants	7,21M	8,01M	7,71M	7,42M	7,15M	6,87M	6,55M	6,26M
Capitaux propres ordinaire	25k	25k	25k	34k	34k	34k	34k	34k
Bénéfices non distribués	-250,18M	-273,22M	-295,47M	-316,78M	-343,08M	-368,4M	-396,05M	-425,08M

Fin d'année 30 Avril 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actif total	24,75M	34,35M	61,39M	118,13M	92,53M	272,01M	203,88M	183,2M
Total de l'actif circulant	24,67M	34,25M	59,38M	115,55M	88,7M	264,26M	193,65M	172,33M
Trésorerie et équivalents	21,76M	30,95M	51,06M	32,01M	15,79M	50,59M	30,73M	56,24M
Total des actifs non courants	-37,11M	31,33M	27,25M	96,74M	83,75M	257,19M	185,09M	161,03M
Total des passifs	61,86M	3,02M	34,14M	21,39M	8,78M	14,82M	18,79M	22,18M
Total des passifs courants	3,25M	3,02M	23,22M	18,05M	7,72M	9,77M	11,58M	15,03M
Total des passifs non courants	58,61M	0	10,98M	3,34M	1,06M	5,05M	7,21M	7,15M
Total des capitaux propres	-37,11M	31,33M	27,25M	96,74M	83,75M	257,19M	185,09M	161,03M
Capitaux propres ordinaire	3k	10k	11k	17k	18k	24k	25k	34k
Bénéfices non distribués	-37,25M	-55,86M	-71,66M	-92,48M	-121,59M	-167,84M	-250,18M	-343,08M